401k Plan data: SKINCURE ONCOLOGY plan

SKINCURE ONCOLOGY 401k Plan overview

Plan Name	SKINCURE ONCOLOGY
Plan identification number	001

SKINCURE ONCOLOGY Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

SKIN CURE ONCOLOGY LLC has sponsored the creation of one or more 401k plans.

Company Name: SKIN CURE ONCOLOGY LLC

Employer identification number (EIN): 812907627

NAIC Classification: 561300

Form 5500 Filing Information

Submission information for form 5500 for 401k plan SKINCURE ONCOLOGY

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01 KAREN TRAINOR 2023-10-10 KAREN TRAINOR 2023-10-10
001 2021-01-01 KAREN TRAINOR 2022-10-17 KAREN TRAINOR 2022-10-17
001 2020-01-01 KAREN TRAINOR 2021-10-15 KAREN TRAINOR 2021-10-15
001 2019-01-01
001 2018-01-01 KAREN JACKSON 2019-07-29
001 2017-01-01 KAREN JACKSON 2018-09-04
001 2016-10-01 PAULINA REMIASZ 2017-07-13

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
001	2022-01-01	KAREN TRAINOR	2023-10-10	KAREN TRAINOR	2023-10-10
001	2021-01-01	KAREN TRAINOR	2022-10-17	KAREN TRAINOR	2022-10-17
001	2020-01-01	KAREN TRAINOR	2021-10-15	KAREN TRAINOR	2021-10-15
001	2019-01-01
001	2018-01-01	KAREN JACKSON	2019-07-29
001	2017-01-01	KAREN JACKSON	2018-09-04
001	2016-10-01	PAULINA REMIASZ	2017-07-13

Plan Statistics for SKINCURE ONCOLOGY

401k plan membership statisitcs for SKINCURE ONCOLOGY

Measure Date Value
2022: SKINCURE ONCOLOGY 2022 401k membership
Total participants, beginning-of-year 2022-01-01 317
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 377
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 43
Total of all active and inactive participants 2022-01-01 420
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 420
Number of participants with account balances 2022-01-01 264
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 0
2021: SKINCURE ONCOLOGY 2021 401k membership
Total participants, beginning-of-year 2021-01-01 261
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 270
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 38
Total of all active and inactive participants 2021-01-01 308
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 308
Number of participants with account balances 2021-01-01 209
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 0
2020: SKINCURE ONCOLOGY 2020 401k membership
Total participants, beginning-of-year 2020-01-01 206
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 233
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 24
Total of all active and inactive participants 2020-01-01 257
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 257
Number of participants with account balances 2020-01-01 159
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 0

Measure	Date	Value
2022: SKINCURE ONCOLOGY 2022 401k membership
Total participants, beginning-of-year	2022-01-01	317
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	377
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	43
Total of all active and inactive participants	2022-01-01	420
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	420
Number of participants with account balances	2022-01-01	264
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	0
2021: SKINCURE ONCOLOGY 2021 401k membership
Total participants, beginning-of-year	2021-01-01	261
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	270
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	38
Total of all active and inactive participants	2021-01-01	308
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	308
Number of participants with account balances	2021-01-01	209
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	0
2020: SKINCURE ONCOLOGY 2020 401k membership
Total participants, beginning-of-year	2020-01-01	206
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	233
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	24
Total of all active and inactive participants	2020-01-01	257
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	257
Number of participants with account balances	2020-01-01	159
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	0

Financial Data on SKINCURE ONCOLOGY

Measure	Date	Value
2022 : SKINCURE ONCOLOGY 2022 401k financial data
Total income from all sources (including contributions)	2022-12-31	$1,361,946
Total of all expenses incurred	2022-12-31	$157,882
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$147,684
Expenses. Certain deemed distributions of participant loans	2022-12-31	$3,698
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$2,509,719
Value of total assets at end of year	2022-12-31	$7,021,750
Value of total assets at beginning of year	2022-12-31	$5,817,686
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$6,500
Total interest from all sources	2022-12-31	$5,448
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$500,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$1,500,965
Participant contributions at end of year	2022-12-31	$141,799
Participant contributions at beginning of year	2022-12-31	$123,049
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$365,463
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$1,204,064
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$7,021,750
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$5,817,686
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$6,851,838
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$5,605,959
Value of interest in pooled separate accounts at end of year	2022-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2022-12-31	$0
Interest on participant loans	2022-12-31	$5,448
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2022-12-31	$28,113
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2022-12-31	$88,678
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-1,153,221
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$643,291
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$147,684
Contract administrator fees	2022-12-31	$6,500
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	WEISS & COMPANY LLP
Accountancy firm EIN	2022-12-31	362663249
2021 : SKINCURE ONCOLOGY 2021 401k financial data
Total income from all sources (including contributions)	2021-12-31	$2,421,216
Total of all expenses incurred	2021-12-31	$93,583
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$88,404
Expenses. Certain deemed distributions of participant loans	2021-12-31	$929
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$1,789,139
Value of total assets at end of year	2021-12-31	$5,817,686
Value of total assets at beginning of year	2021-12-31	$3,490,053
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$4,250
Total interest from all sources	2021-12-31	$3,997
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$500,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$975,151
Participant contributions at end of year	2021-12-31	$123,049
Participant contributions at beginning of year	2021-12-31	$61,103
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$350,634
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$2,327,633
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$5,817,686
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$3,490,053
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$5,605,959
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$3,371,934
Interest on participant loans	2021-12-31	$3,997
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2021-12-31	$88,678
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2021-12-31	$57,016
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$628,080
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$463,354
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$88,404
Contract administrator fees	2021-12-31	$4,250
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	WEISS & COMPANY LLP
Accountancy firm EIN	2021-12-31	362663249
2020 : SKINCURE ONCOLOGY 2020 401k financial data
Total income from all sources (including contributions)	2020-12-31	$1,664,471
Total of all expenses incurred	2020-12-31	$94,196
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$86,599
Expenses. Certain deemed distributions of participant loans	2020-12-31	$4,597
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$1,196,646
Value of total assets at end of year	2020-12-31	$3,490,053
Value of total assets at beginning of year	2020-12-31	$1,919,778
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$3,000
Total interest from all sources	2020-12-31	$1,856
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$350,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$709,464
Participant contributions at end of year	2020-12-31	$61,103
Participant contributions at beginning of year	2020-12-31	$26,603
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$136,691
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$1,570,275
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$3,490,053
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$1,919,778
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$3,371,934
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$1,877,209
Interest on participant loans	2020-12-31	$1,856
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2020-12-31	$57,016
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2020-12-31	$15,966
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$465,969
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$350,491
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$86,599
Contract administrator fees	2020-12-31	$3,000
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	WEISS & COMPANY LLP
Accountancy firm EIN	2020-12-31	362663249

Form 5500 Responses for SKINCURE ONCOLOGY

2022: SKINCURE ONCOLOGY 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Insurance	Yes
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement – Insurance	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: SKINCURE ONCOLOGY 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Insurance	Yes
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement – Insurance	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: SKINCURE ONCOLOGY 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Insurance	Yes
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement – Insurance	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

VOYA RETIRIEMENT INSURANCE AND ANNUITY COMPANY (National Association of Insurance Commissioners NAIC id number: 86509 )

Policy contract number

81C222

Policy instance

Insurance contract or identification number	81C222
Number of Individuals Covered	266
Insurance policy start date	2022-01-01
Insurance policy end date	2022-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

VOYA RETIRIEMENT INSURANCE AND ANNUITY COMPANY (National Association of Insurance Commissioners NAIC id number: 86509 )

Policy contract number

81C222

Policy instance

Insurance contract or identification number	81C222
Number of Individuals Covered	211
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

VOYA RETIRIEMENT INSURANCE AND ANNUITY COMPANY (National Association of Insurance Commissioners NAIC id number: 86509 )

Policy contract number

81C222

Policy instance

Insurance contract or identification number	81C222
Number of Individuals Covered	159
Insurance policy start date	2020-01-01
Insurance policy end date	2020-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $224
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Amount paid for insurance broker fees	224
Insurance broker organization code?	5

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	SKIN CURE ONCOLOGY LLC
Employer identification number (EIN):	812907627
NAIC Classification:	561300